Ciprofloxacin hydrochloride eye drops

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

The main ingredient of this product is ciprofloxacin hydrochloride.

Used for external eye infections caused by sensitive bacteria (such as conjunctivitis, etc.).

Apply inside the eyelid, 1 to 2 drops at a time, 3 to 6 times a day, for 6 to 14 days.

Occasionally, there are transient local irritation symptoms. Local burning and foreign body sensation may occur. In addition, eyelid edema, tearing, photophobia, decreased vision, and allergic reactions are less common.

Patients who are allergic to this product and quinolones are contraindicated.

Long-term and excessive use, after local absorption, can produce the same drug interactions as systemic medications, such as increasing the blood concentrations of drugs such as theophylline, cyclosporine, and probenecid, enhancing the anticoagulant effect of the anticoagulant warfarin, and interfering with the metabolism of caffeine.

Keep away from light and store in a sealed container.

8ml:24mg

24 months

Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.

• Founded in:

  1992-03-31

• Address:

  No. 789, Xinluo Street, Jinan High-tech Development Zone

• Tax NO.:

  913701006140705563

• Registered Funds:

  90 million yuan

• Website:

  Log in to view

• Email:

  Log in to view